F.D.A. Reviewing H.I.V. Drugs for Heart Risk
The Food and Drug Administration said on Thursday that recent data show patients taking H.I.V. drugs from GlaxoSmithKline and Bristol-Myers Squibb may have increased risk of heart attack.
The Food and Drug Administration said on Thursday that recent data show patients taking H.I.V. drugs from GlaxoSmithKline and Bristol-Myers Squibb may have increased risk of heart attack.